Nanotechnology Inclusion in Pharmaceutical Sciences Education in Portugal.

José das Neves
Author Information
  1. José das Neves: Instituto de Investigação e Inovação em Saúde (i3S) and Instituto de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal.

Abstract

To analyze the inclusion of nanotechnology in the curricula of Integrated Master's in Pharmaceutical Sciences programs in Portugal. Information regarding curricula (general notice and curricular unit description, objectives and syllabus) from national institutions was collected from their official websites or requested by e-mail, and analyzed for the occurrence of nanotechnology and related terms. A nanotechnology inclusion in curriculum (NIC) index was developed and used to rank each institution. All institutions with available data (eight out of nine) offered nanotechnology in their curricula. Both basic and applied nanotechnology-related education were offered to students but mostly from a theoretical perspective. The NIC index provided a standardized tool for comparing the institutions' programs and highlighted differences according to the relative importance of the presence of nanotechnology and related terms in curricula. Portuguese institutions offering integrated master's programs in pharmaceutical sciences are including nanotechnology in their curricula. However, its implementation across all institutions remains weak and requires further strengthening to meet the requirements of this emerging field in health care practice.

Keywords

References

  1. Angew Chem Int Ed Engl. 2014 Nov 10;53(46):12304-19 [PMID: 25302857]
  2. Int J Nanomedicine. 2014 Sep 15;9:4357-73 [PMID: 25258527]
  3. Adv Drug Deliv Rev. 2014 Sep 30;76:79-97 [PMID: 25116445]
  4. J Pharm Sci. 2007 Oct;96(10):2547-65 [PMID: 17688284]
  5. Physiotherapy. 2011 Jun;97(2):145-53 [PMID: 21497249]
  6. BMJ. 2015 Jul 14;351:h3735 [PMID: 26173948]
  7. Am J Pharm Educ. 2008 Aug 15;72(4):89 [PMID: 19002287]
  8. ACS Nano. 2009 Jan 27;3(1):16-20 [PMID: 19206243]
  9. Br J Pharmacol. 2014 Sep;171(17):3961-2 [PMID: 25113563]
  10. N Engl J Med. 2010 Dec 16;363(25):2434-43 [PMID: 21158659]
  11. Am J Pharm Educ. 2008 Feb 15;72(1):09 [PMID: 18322571]
  12. Int J Nanomedicine. 2014 May 05;9 Suppl 1:1-5 [PMID: 24872698]
  13. Chem Rev. 2015 Oct 14;115(19):10938-66 [PMID: 26010257]
  14. Curr Drug Metab. 2015;16(8):645-61 [PMID: 26560320]
  15. Beilstein J Nanotechnol. 2015 Aug 21;6:1769-80 [PMID: 26425429]
  16. Indian J Pharmacol. 2014 May-Jun;46(3):241-5 [PMID: 24987167]
  17. Nanomedicine. 2013 Jan;9(1):1-14 [PMID: 22684017]
  18. Front Psychol. 2011 Mar 03;2:28 [PMID: 21713171]
  19. Adv Drug Deliv Rev. 2014 Jul;74:28-34 [PMID: 24862579]
  20. J Allied Health. 2016 Fall;45(3):168-75 [PMID: 27585612]

MeSH Term

Academies and Institutes
Curriculum
Education, Pharmacy
Humans
Nanotechnology
Pharmaceutical Research
Portugal

Word Cloud

Created with Highcharts 10.0.0nanotechnologycurriculainstitutionsprogramsinclusionPharmaceuticalSciencesPortugalcurricularunitrelatedtermsNICindexofferededucationanalyzeIntegratedMaster'sInformationregardinggeneralnoticedescriptionobjectivessyllabusnationalcollectedofficialwebsitesrequestede-mailanalyzedoccurrencecurriculumdevelopedusedrankinstitutionavailabledataeightninebasicappliednanotechnology-relatedstudentsmostlytheoreticalperspectiveprovidedstandardizedtoolcomparinginstitutions'highlighteddifferencesaccordingrelativeimportancepresencePortugueseofferingintegratedmaster'spharmaceuticalsciencesincludingHoweverimplementationacrossremainsweakrequiresstrengtheningmeetrequirementsemergingfieldhealthcarepracticeNanotechnologyInclusionEducationnanomedicinenanosciencepharmacistpharmacy

Similar Articles

Cited By